[PDF] Intellectual Property Rights And The Life Science Industries eBook

Author : Graham Dutfield
Publisher : Routledge
Page : 301 pages
File Size : 21,8 MB
Release : 2017-03-02
Category : Law
ISBN : 1351927132

GET BOOK

This book analyses the history of the international patent regime and the life science industries, both of which can be traced back to the late 19th century. The development of patent law is inextricably linked to expanding capacities to elucidate, manipulate and commercially exploit the molecular properties of micro-organisms, plants, animals and other organic raw materials. The story of the life science industries begins with the European synthetic dyestuff firms and culminates in present-day conglomerates like Aventis, Novartis and Pharmacia. Throughout the last century, chemical, pharmaceutical, seed and biotechnology firms were actively involved in reforming patent law and plant variety rights. The major beneficiaries have been the largest firms whose market dominance and influence over peoples' lives - aided by friendly intellectual property laws - has never been greater. This sparkling and stimulating book reveals the key repercussions caused by the expansion of life science industries for issues of international equity, public health, food security and biological diversity.

Author : Graham Dutfield
Publisher : World Scientific
Page : 429 pages
File Size : 25,34 MB
Release : 2009
Category : Law
ISBN : 9812832289

GET BOOK

This book is a highly readable and entertaining account of the co-evolution of the patent system and the life science industries since the mid-19th century. The pharmaceutical industries have their origins in advances in synthetic chemistry and in natural products research. Both approaches to drug discovery and business have shaped patent law, as have the lobbying activities of the firms involved and their supporters in the legal profession. In turn, patent law has impacted on the life science industries. Compared to the first edition, which told this story for the first time, the present edition focuses more on specific businesses, products and technologies, including Bayer, Pfizer, GlaxoSmithKline, aspirin, penicillin, monoclonal antibodies and polymerase chain reaction. Another difference is that this second edition also looks into the future, addressing new areas such as systems biology, stem cell research, and synthetic biology, which promises to enable scientists to OC inventOCO life forms from scratch.

Author : Graham Dutfield
Publisher : Earthscan
Page : 240 pages
File Size : 45,86 MB
Release : 2000
Category : Law
ISBN : 1849776237

GET BOOK

This text examines the international agreements governing trade in genetic resources - crucial resources for world agriculture, food security and large industries such as pharmaceuticals. Intellectual Property Rights (IPRs) in these resources are critical for those involved in the trade, including industry and developing countries. The book analyzes the Convention on Biological Diversity (CBD), World Trade Organization agreements and other agreements. It explains how they can be integrated into an equitable training regime.

Author : Paul England
Publisher :
Page : 0 pages
File Size : 26,55 MB
Release : 2015
Category : Business & Economics
ISBN : 9781909416697

GET BOOK

Subjects explored within the national chapters include small molecules, secondary patents, DNA and biologicals, patent infringement and enforcement, compulsory licensing, branding and designs, counterfeiting and know-how protection, and patenting and supplementary protection certificates (SPCs) in personalised medicine.

Author : Duncan Matthews
Publisher : Edward Elgar Publishing
Page : 529 pages
File Size : 10,14 MB
Release : 2017-06-30
Category : Law
ISBN : 1783479450

GET BOOK

Intellectual property (IP) is a key component of the life sciences, one of the most dynamic and innovative fields of technology today. At the same time, the relationship between IP and the life sciences raises new public policy dilemmas. The Research Handbook on Intellectual Property and the Life Sciences comprises contributions by leading experts from academia and industry to provide in-depth analyses of key topics including pharmaceuticals, diagnostics and genes, plant innovations, stem cells, the role of competition law and access to medicines. The Research Handbook focuses on the relationship between IP and the life sciences in Europe and the United States, complemented by country-specific case studies on Australia, Brazil, China, India, Japan, Kenya, South Africa and Thailand to provide a truly international perspective.

Author : National Research Council
Publisher : National Academies Press
Page : 457 pages
File Size : 43,4 MB
Release : 1993-02-01
Category : Political Science
ISBN : 0309048338

GET BOOK

As technological developments multiply around the globeâ€"even as the patenting of human genes comes under serious discussionâ€"nations, companies, and researchers find themselves in conflict over intellectual property rights (IPRs). Now, an international group of experts presents the first multidisciplinary look at IPRs in an age of explosive growth in science and technology. This thought-provoking volume offers an update on current international IPR negotiations and includes case studies on software, computer chips, optoelectronics, and biotechnologyâ€"areas characterized by high development cost and easy reproducibility. The volume covers these and other issues: Modern economic theory as a basis for approaching international IPRs. U.S. intellectual property practices versus those in Japan, India, the European Community, and the developing and newly industrializing countries. Trends in science and technology and how they affect IPRs. Pros and cons of a uniform international IPRs regime versus a system reflecting national differences.

Author : Arnold & Porter Kaye Scholer Llp
Publisher :
Page : 1204 pages
File Size : 37,57 MB
Release : 2019-06-07
Category : Bioethics
ISBN : 9781402431388

GET BOOK

Pharmaceutical and Biotech Patent Law provides you with the legal, scientific, and technical information you need to help clients obtain, defend, and challenge patents in these important business areas. This practical guide shows you how to craft problem-free patent applications, including how to partner with the government to bring patented inventions quickly to the marketplace - invalidate competitors' patents by proving that they fail to meet key requirements - protect against various forms of patent infringement - and successfully rebut charges of infringement. It includes detailed checklists that help you resolve thorny patent problems in the complex pharmaceutical and biotech fields, and is regularly updated to reflect Federal Circuit rulings and other significant court decisions.

Author : Chidi Oguamanam
Publisher :
Page : 0 pages
File Size : 42,30 MB
Release : 2015
Category :
ISBN :

GET BOOK

The pharmaceutical industry has greatly benefitted from using intellectual property law to optimize investment in pharmaceutical research and development. Graham Dutfield's book explores how that came to be, and what the future may hold for the continued co-evolution of life sciences, business and intellectual property regimes, especially patents. This work mainly discusses what it means to 'invent' in the life sciences, and how patent law in this area is shaped not only by economic interests, but also by highly contestable assumptions concerning life, science and the boundaries to be drawn between the natural and the human-made. Graham Dutfield's analysis is accessible, balanced, and concise. This volume is an appropriate and compelling read for a wide audience from different disciplinary and professional backgrounds.

Author : Claude E. Barfield
Publisher : A E I Press
Page : 116 pages
File Size : 10,50 MB
Release : 2007
Category : Law
ISBN : 9780844742564

GET BOOK

American patent law has reached an unprecedented crossroads, prodded by a landmark Supreme Court decision this spring and the prospect of sweeping new federal legislation this fall. At this critical time, Biotechnology and the Patent System: Balancing Innovation and Property Rights provides a timely look at the complex issues involved in making patent law for cutting-edge high-tech industries such as the biotechnology and computer software sectors.